Björn Nowack
Managing Director, SensID GmbH
Björn Nowack is listed as Managing Director, SensID GmbH. Björn is scheduled to speak at MEDICA 2026 on 18 November 2026.
Compiled from published conference agendas; not yet confirmed by Björn. Is this you? Claim this profile.
About
Björn Nowack is Managing Director of SensID GmbH, a Microbiologics company, and Vice President of Precision Medicine at Microbiologics. A biochemist by training, he brings experience in molecular diagnostics, laboratory management, and pharmaceutical quality assurance. His work focuses on strategy, scientific partnerships, and reference materials that support reliable molecular testing.
Upcoming
MEDICA 2026 16 November 2026 – 19 November 2026
- Case of the Day: Precision Diagnostics - Biomarkers. Innovation. Impact. Speaker · 18 November 2026
- Making Precision Diagnostics Reliable – The Role of Quality Control Speaker · 18 November 2026
- Reverse Panel: Precision Diagnostics - Biomarkers. Innovation. Impact. Speaker · 18 November 2026
Spoke alongside
People who have shared a session with Björn at events on B2DB.
- Ariane Hallermayr Head of Research and Development · MGZ – Medical Genetics Center 2 shared sessions
- Maximilian Christopeit Attending Physician · University Medical Center Hamburg-Eppendorf 2 shared sessions
- Nils Große Hokamp Senior Managing Radiologist · University Hospital of Cologne 2 shared sessions
- Verena Haselmann Professor of Translational Precision Diagnostics · Universitätsklinikum Hamburg-Eppendorf 2 shared sessions